Published in Mol Microbiol on March 01, 2000
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother (2006) 3.38
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
Biodegradation of aromatic compounds by Escherichia coli. Microbiol Mol Biol Rev (2001) 2.50
Mgr, a novel global regulator in Staphylococcus aureus. J Bacteriol (2003) 2.14
MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region. J Bacteriol (2001) 1.86
CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother (2005) 1.83
FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism. J Bacteriol (2003) 1.25
mar Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob Agents Chemother (2002) 1.23
Crystal structure of the virulence gene activator AphA from Vibrio cholerae reveals it is a novel member of the winged helix transcription factor superfamily. J Biol Chem (2005) 1.21
The mexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutations compromising activity. J Bacteriol (2002) 1.11
Expression of a cloned cyclopropane fatty acid synthase gene reduces solvent formation in Clostridium acetobutylicum ATCC 824. Appl Environ Microbiol (2003) 1.10
Identification and functional characterization of CbaR, a MarR-like modulator of the cbaABC-encoded chlorobenzoate catabolism pathway. Appl Environ Microbiol (2001) 1.09
Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA. Nucleic Acids Res (2009) 1.05
Structural and functional analysis of the transcriptional regulator Rv3066 of Mycobacterium tuberculosis. Nucleic Acids Res (2012) 1.00
Mutations affecting DNA-binding activity of the MexR repressor of mexR-mexA-mexB-oprM operon expression. J Bacteriol (2003) 1.00
Genetic determinants of Silicibacter sp. TM1040 motility. J Bacteriol (2009) 1.00
Genetic and structural organization of the aminophenol catabolic operon and its implication for evolutionary process. J Bacteriol (2001) 0.97
Detection and functional characterization of a 215 amino acid N-terminal extension in the Xanthomonas type III effector XopD. PLoS One (2010) 0.95
Functional characterization of a lipoprotein-encoding operon in Campylobacter jejuni. PLoS One (2011) 0.93
Identification and characterization of a novel multidrug resistance operon, mdtRP (yusOP), of Bacillus subtilis. J Bacteriol (2009) 0.91
LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule. J Biol Chem (2010) 0.89
Interaction of Borrelia burgdorferi Hbb with the p66 promoter. Nucleic Acids Res (2009) 0.85
Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance. Protein Sci (2010) 0.83
Structural mechanism of transcription regulation of the Staphylococcus aureus multidrug efflux operon mepRA by the MarR family repressor MepR. Nucleic Acids Res (2013) 0.82
Genetic Basis and Functional Consequences of Differential Expression of the CmeABC Efflux Pump in Campylobacter jejuni Isolates. PLoS One (2015) 0.80
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2016) 0.80
SlyA regulates type III secretion system (T3SS) genes in parallel with the T3SS master regulator HrpL in Dickeya dadantii 3937. Appl Environ Microbiol (2012) 0.79
Retracted GyrA interacts with MarR to reduce repression of the marRAB operon in Escherichia coli. J Bacteriol (2009) 0.78
An oxidoreductase is involved in cercosporin degradation by the bacterium Xanthomonas campestris pv. zinniae. Appl Environ Microbiol (2006) 0.77
Structural characterization of the DNA-binding mechanism underlying the copper(II)-sensing MarR transcriptional regulator. J Biol Inorg Chem (2017) 0.77
The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of Staphylococcus aureus. MBio (2013) 0.76
Tigecycline non-susceptibility occurs exclusively in fluoroquinolone-resistant Escherichia coli clinical isolates, including the major multidrug-resistant lineages O25b:H4-ST131-H30R and O1-ST648. Antimicrob Agents Chemother (2016) 0.75
Dual Repression of the Multidrug Efflux Pump CmeABC by CosR and CmeR in Campylobacter jejuni. Front Microbiol (2016) 0.75
AutA and AutR, Two Novel Global Transcriptional Regulators, Facilitate Avian Pathogenic Escherichia coli Infection. Sci Rep (2016) 0.75
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci U S A (1980) 8.43
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol (1983) 7.06
Heterogeneity of tetracycline resistance determinants. Plasmid (1980) 6.42
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol (1993) 6.02
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother (1989) 5.09
marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol (1988) 4.97
Triclosan targets lipid synthesis. Nature (1998) 4.70
Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob Agents Chemother (1988) 4.47
Control of circadian rhythms and photoperiodic flowering by the Arabidopsis GIGANTEA gene. Science (1999) 4.42
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother (1997) 4.40
Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol (1983) 4.37
Diversity of mucin genes, structure, function, and expression. Gastroenterology (1995) 3.97
Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol (1993) 3.95
Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance. Biochem Biophys Res Commun (1974) 3.93
marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol (1991) 3.83
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol (1997) 3.81
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother (2001) 3.62
Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems. Appl Environ Microbiol (1988) 3.52
The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat Struct Biol (2001) 3.52
Synthesis of an R plasmid protein associated with tetracycline resistance is negatively regulated. Proc Natl Acad Sci U S A (1976) 3.32
Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem (1994) 3.29
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol (2000) 3.27
Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med (1976) 3.16
Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli. J Bacteriol (1994) 3.13
Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect (2006) 3.04
Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res (1993) 3.02
The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol (1999) 2.97
Two complementation groups mediate tetracycline resistance determined by Tn10. J Bacteriol (1982) 2.96
T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (1994) 2.81
Course of tic severity in Tourette syndrome: the first two decades. Pediatrics (1998) 2.75
Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob Agents Chemother (1978) 2.68
Multidrug resistance--a sign of the times. N Engl J Med (1998) 2.68
Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature (1976) 2.67
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother (1998) 2.59
Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms. Antimicrob Agents Chemother (1983) 2.58
Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem (1989) 2.57
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol (1995) 2.55
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54
Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature (1978) 2.50
Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A (1985) 2.44
Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. J Nerv Ment Dis (1990) 2.42
Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother (1993) 2.40
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother (2000) 2.40
R factor proteins synthesized in Escherichia coli minicells: incorporation studies with different R factors and detection of deoxyribonucleic acid-binding proteins. J Bacteriol (1974) 2.39
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.34
An equilibrium between two fractions of lipopolysaccharide in Escherichia coli. Proc Natl Acad Sci U S A (1968) 2.33
Segregation of transferable R factors into Escherichia coli minicells. Nature (1970) 2.26
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A (1997) 2.24
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett (1998) 2.24
Two-dimensional IR spectroscopy can be designed to eliminate the diagonal peaks and expose only the crosspeaks needed for structure determination. Proc Natl Acad Sci U S A (2001) 2.21
Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17
Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation. Transpl Infect Dis (2013) 2.09
Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. J Bacteriol (1999) 2.04
The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem (1992) 1.98
Development of an Adhesion Assay and Characterization of an Adhesion-Deficient Mutant of Pseudomonas fluorescens. Appl Environ Microbiol (1990) 1.96
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry (2001) 1.95
A new tetracycline-resistance determinant, class E, isolated from Enterobacteriaceae. Gene (1986) 1.95
Physical and functional characteristics of R-factor deoxyribonucleic acid segregated into Escherichia coli minicells. J Bacteriol (1971) 1.94
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res (1989) 1.93
Selenocysteine tRNA[Ser]Sec gene is ubiquitous within the animal kingdom. Mol Cell Biol (1990) 1.91
Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90
Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem (1993) 1.90
Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol (2011) 1.89
Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun (1990) 1.88
Very stable prokaryotic messenger RNA in chromosomeless Escherichia coli minicells. Proc Natl Acad Sci U S A (1975) 1.87
Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J Infect Dis (2001) 1.85
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82
Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrob Agents Chemother (1982) 1.80
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant (2012) 1.79
Resistance of minicells to penicillin lysis: a method of obtaining large quantities of purified minicells. J Bacteriol (1970) 1.79
Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother (2003) 1.78
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78
Relationship between sonographic and pathologic findings in epidermal inclusion cysts. J Clin Ultrasound (2001) 1.77
Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology (1994) 1.77
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77
The fallacy of the levator expansion theory. Plast Reconstr Surg (1999) 1.75
Identification of new genes regulated by the marRAB operon in Escherichia coli. J Bacteriol (1995) 1.75
Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res (2001) 1.73
Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother (1987) 1.72
Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants. Antimicrob Agents Chemother (1994) 1.71
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (1990) 1.70
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (2000) 1.69
Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem (1989) 1.68
A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J Infect Dis (1993) 1.68
A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem (1988) 1.67
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother (1999) 1.67
R factor proteins synthesized in Escherichia coli minicells: membrane-associated R factor proteins. J Bacteriol (1974) 1.67
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation (2001) 1.67
Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res (1995) 1.66
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res (1998) 1.66
Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli. Antimicrob Agents Chemother (1981) 1.66
A gene cluster encoding malonyl-CoA decarboxylase (MatA), malonyl-CoA synthetase (MatB) and a putative dicarboxylate carrier protein (MatC) in Rhizobium trifolii--cloning, sequencing, and expression of the enzymes in Escherichia coli. Eur J Biochem (1998) 1.66
Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology (2000) 1.65
Glycoprortein biosynthesis in small intestinal mucosa. I. A study of glycosyltransferases in microsomal subfractions. J Biol Chem (1971) 1.65
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis (1999) 1.63
Antimicrobial resistance: a plan of action for community practice. Am Fam Physician (2001) 1.63
Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother (1997) 1.61